Search Results: "NIH"
-
Drug and Digital Technologies Are Part of NIH’s Long Covid Clinical Trial Plans
Long Covid continues to afflict patients and mystify clinicians. The National Institutes of Health is trying to identify potential treatments and it is launching a series of clinical trials that will assess a wide range of therapeutic interventions.
-
NIH Marburg Vaccine Posts Encouraging Results in First-in-Human Study
Marburg virus has no FDA-approved vaccines or therapies, but a vaccine candidate from the National Institutes of Health now has encouraging results from a U.S. clinical trial. Next steps include tests in more countries including Ghana, where a Marburg outbreak was declared last summer.
-
Collins’ skillfulpiloting helped NIH steer clear of political minefields
The motorcycle-riding, guitar-playing Collins announced Tuesday he will step down by the end of the year from his job as chief of the research agency, having served more than a dozen years under three presidents.
-
AstraZeneca’s Covid-19 vaccine data may have ‘outdated information,’ NIH cautions
Federal health authorities say safety observers are concerned AstraZeneca did not release complete information about the efficacy of its Covid-18 vaccine. The company responded by saying its data were from a pre-specified analysis and it will provide the most up to date efficacy data within 48 hours.
-
NIH panel contradicts FDA on authorization for convalescent plasma in Covid-19
The agency’s Covid-19 Treatment Guidelines Panel stated there was insufficient evidence for or against the treatment and pointed out that in certain groups, such as intubated patients, no benefit in seven-day overall survival was observed.
-
Gilead Covid-19 drug remdesivir benefited from $6.5B in NIH-funded basic research, study finds
Research on the drug’s molecular target dates back to the 1950s. A spokesperson for Gilead noted that the company anticipates potentially investing more than $1 billion on the drug this year alone.
-
Moderna reports positive – but still early – data from NIH Covid-19 vaccine trial
The company said eight participants dosed at 25 or 100 micrograms achieved concentrations of neutralizing antibodies against the SARS-CoV-2 virus at levels comparable to or exceeding those of Covid-19 patients who had recovered.
-
Trump’s favorite drug for Covid-19 smacked down in VA study, NIH guidance
A preprint retrospective analysis among 368 patients hospitalized with Covid-19 in the VA system found no benefit and a higher degree of death from hydroxychloroquine. A panel of experts also recommended against using the drug with azithromycin outside of trials due to potential toxicity.
-
NIH opens Phase II coronavirus trial with Gilead drug at University of Nebraska
The randomized, placebo-controlled study of Gilead’s remdesivir has been posted online and has enrolled the first patient, one of the passengers on a quarantined cruise ship docked off of Yokohama, Japan, who was repatriated to the U.S.
-
Trump’s proposed NIH cuts show disregard for importance of basic research
It’s likely that many drugs Americans take for granted wouldn’t exist today if not for the NIH-funded basic research that enabled their discovery and development. Fortunately, generous funding for the NIH has long enjoyed bipartisan support in Congress.
-
NIH, Gates Foundation invest $200M to develop gene therapies for developing countries
The partnership will have a particular focus on therapies to treat sickle cell disease and HIV, with each party committing $100 million to the effort.
-
BioPharma, Diagnostics, Health Services
NIH research initiative All of Us funds Color Genomics as its genetic counseling service
The partnership builds on an existing relationship between All of Us and Color, which was chosen as one of three genome centers that are responsible for actual genotyping of patient samples.
-
Startups, Devices & Diagnostics
Stroke recovery startup Flint Rehab nabs another NIH grant
With the additional $1.72 million in grants for further development of its stroke rehab technology, the Irvine, California-based company’s funding now totals more than $8 million.
-
Devices & Diagnostics, Diagnostics
Fitbit and NIH boost precision medicine research partnership
Fitbit users can now link their accounts to All of Us precision medicine research project to help researchers better understand the relationship between fitness and wellness metrics and larger health outcomes.
-
Administration stops NIH scientists from obtaining fetal tissue, possibly threatening HIV research
Science magazine reported that the move put the brakes on a preclinical HIV study and follows the cancellation of a contract between the FDA and a California-based company that supplies fetal tissue for medical research.